BACKGROUND: Recent studies suggest an increased incidence of acute infection with hepatitisC virus (AHC) in men who have sex with men (MSM) co-infected with HIV. Early treatment with interferon-alpha, alone or in combination with ribavirin, significantly reduces the risk of chronic evolution. METHODS: This retrospective study includes all HIV patients with AHC in our centre from 2003 to March 2013. AHC was defined by seroconversion of HCV antibodies and detection of serum HCV RNA. RESULTS: 93 episodes of AHC were diagnosed in 89 patients. All but three were MSM with a history of unprotected sex. Thirty-seven (40%) patients had other associated sexually transmitted disease. The 29% (27) had any symptoms suggestive of AHC. HCV genotype 4 was the most common (41%), followed by genotype1. Seventy patients started treatment with interferon-alfa and weight-adjusted ribavirin. Currently 46 have completed treatment and follow-up, reaching 26 of them (56.5%) sustained viral response. CONCLUSIONS: The incidence of AHC in HIV MSM patients from our centre has increased exponentially in recent years; sexual transmission remains the main route of infection. Early treatment with interferon-alpha and ribavirin achieved a moderate response in these patients.
BACKGROUND: Recent studies suggest an increased incidence of acute infection with hepatitisC virus (AHC) in men who have sex with men (MSM) co-infected with HIV. Early treatment with interferon-alpha, alone or in combination with ribavirin, significantly reduces the risk of chronic evolution. METHODS: This retrospective study includes all HIVpatients with AHC in our centre from 2003 to March 2013. AHC was defined by seroconversion of HCV antibodies and detection of serum HCV RNA. RESULTS: 93 episodes of AHC were diagnosed in 89 patients. All but three were MSM with a history of unprotected sex. Thirty-seven (40%) patients had other associated sexually transmitted disease. The 29% (27) had any symptoms suggestive of AHC. HCV genotype 4 was the most common (41%), followed by genotype1. Seventy patients started treatment with interferon-alfa and weight-adjusted ribavirin. Currently 46 have completed treatment and follow-up, reaching 26 of them (56.5%) sustained viral response. CONCLUSIONS: The incidence of AHC in HIV MSMpatients from our centre has increased exponentially in recent years; sexual transmission remains the main route of infection. Early treatment with interferon-alpha and ribavirin achieved a moderate response in these patients.
Keywords:
Acute hepatitis C; Coinfección por virus de la inmunodeficiencia humana; Enfermedades de transmisión sexual; Hepatitis aguda C; Human immunodeficiency virus co-infection; Incidence; Incidencia; Sexual transmitted diseases
Authors: Karin Neukam; Pompeyo Viciana; Guillermo Ojeda-Burgos; Marcial Delgado-Fernández; María J Ríos; Juan Macías; Dolores Merino; Antonio Collado; Francisco Téllez; Juan A Pineda Journal: BMC Infect Dis Date: 2016-09-15 Impact factor: 3.090
Authors: Juan Berenguer; Inmaculada Jarrín; Leire Pérez-Latorre; Víctor Hontañón; María J Vivancos; Jordi Navarro; María J Téllez; Josep M Guardiola; José A Iribarren; Antonio Rivero-Juárez; Manuel Márquez; Arturo Artero; Luis Morano; Ignacio Santos; Javier Moreno; María C Fariñas; María J Galindo; María A Hernando; Marta Montero; Carmen Cifuentes; Pere Domingo; José Sanz; Lourdes Domíngez; Oscar L Ferrero; Belén De la Fuente; Carmen Rodríguez; Sergio Reus; José Hernández-Quero; Gabriel Gaspar; Laura Pérez-Martínez; Coral García; Lluis Force; Sergio Veloso; Juan E Losa; Josep Vilaró; Enrique Bernal; Sari Arponen; Amat J Ortí; Ángel Chocarro; Ramón Teira; Gerardo Alonso; Rafael Silvariño; Ana Vegas; Paloma Geijo; Josep Bisbe; Herminia Esteban; Juan González-García Journal: Open Forum Infect Dis Date: 2018-01-12 Impact factor: 3.835
Authors: R Boix; R Cano; P Gallego; F Vallejo; R Fernández-Cuenca; I Noguer; A Larrauri Journal: BMC Health Serv Res Date: 2017-07-05 Impact factor: 2.655
Authors: César Garriga; Sandra Manzanares-Laya; Patricia García de Olalla; Pilar Gorrindo; Sabela Lens; Ricard Solà; María Martínez-Rebollar; Montserrat Laguno; Jordi Navarro; Xavier Torras; Mercè Gurguí; María-Jesús Barberá; Josep Quer; Eva Masdeu; Pere Simón; Miriam Ros; Anna de Andrés; Joan A Caylà Journal: PLoS One Date: 2017-11-14 Impact factor: 3.240
Authors: Juan Berenguer; Antonio Rivero; Inmaculada Jarrín; María J Núñez; María J Vivancos; Manel Crespo; María J Téllez; Pere Domingo; José A Iribarren; Arturo Artero; Manuel Márquez; Ignacio Santos; Javier Moreno; Marta Montero; Juan González-García Journal: Open Forum Infect Dis Date: 2016-03-11 Impact factor: 3.835